Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

Assistance Publique - Hôpitaux de Paris30 enrolled

Overview

In this research, we will evaluate the feasibility of following by remote monitoring, using a connected scale, in hematology patients suffering from myeloma or lymphoma and requiring treatment with chemotherapy. 30 patients will be included in the research and will all use a connected scale for the duration of their participation (7 weeks +/- 1 week). During their participation, patients will be asked to weigh themselves once a day, ideally at a set time. Patient data will be accessible by the medical team via a remote monitoring platform. Alerts will be generated in the event of abnormal development of certain clinical parameters (weight, heart rate, etc.) allowing early treatment to be implemented by the medical team. At the end of their participation, we will evaluate patients' support and perception of this tool, as well as the healthcare consequences of the alerts generated by the remote monitoring platform.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Lymphoma, Non-Hodgkin Myeloma Multiple

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient aged 18 and over (male or female) * Patient suffering from aggressive non-Hodgkin's lymphoma or multiple myeloma with a plan for systemic chemotherapy or having started two cycles or less or patient with the need for therapeutic intensification under the cover of autograft in the context of myeloma or lymphoma * Patient who can be contacted by telephone during their participation in the research * Patient able to return home at the end of their initial hospitalization * Patient affiliated to social security * Patient able to read and speak French * Patient having signed free, informed and written consent Exclusion Criteria: * Patient with an estimated life expectancy \< 3 months * Patient with moderate to severe cognitive impairment (assessed by MMSE \< 20) * Patient with a psychiatric or physical disability that does not allow the use of the device * Patient with a pacemaker * Patient participating in another intervention research project * Pregnant patient * Patient deprived of liberty * Patient under legal protection (guardianship or curatorship)

Outcomes

Primary Outcomes

Percentage of patients who agreed to participate in research

Number of included patients / Number of indormed patients

Time frame: Inclusion

Secondary Outcomes

Frequency of use of the connected scale during the patient's participation in the research

Average of weighings/week

Time frame: From inclusion to week 7

Assessment of the patient's anxiety regarding the device

Specific 5 points Likert Scale (1 - 5 ; Higher score mean a worse outcome)

Time frame: week 7

Evaluation of the ease of use of the device perceived by the patient

Symptom Usability Scale (0 - 100 ; Higher score mean a better outcome)

Time frame: week 7

Evaluation of the implementation of the study by the patient

FIM (Feasibility of Intervention Measure), AIM (Acceptability of Intervention Measure) and IAM (Intervention Appropriateness Measure) / (1 - 5 ; Higher score mean a better outcome)

Time frame: week 7

Evaluation of the consequences in care of alerts generated by the plateform

Number of alerts generated/patient.

Time frame: From inclusion to week 7

Evaluation of the consequences in care of alerts generated by the plateform

Number of calls made/patient.

Time frame: From inclusion to week 7

Evaluation of the consequences in care of alerts generated by the plateform

Average time spent per call following the generation of an alert.

Time frame: From inclusion to week 7

Evaluation of the consequences in care of alerts generated by the plateform

Number and type of consultations, hospitalizations, additional assessments resulting from the generation of an alert.

Time frame: From inclusion to week 7

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes

Central Contacts